IP Library Assignment 045016/0287
Patent Assignment
Reel/Frame 045016/0287

Change of Name

Recorded: 2018-01-08 Pages: 4
Assignor
THERACOAT LTD.
Executed: 2015-11-09
Assignee
UROGEN PHARMA LTD.
13 HASADNA STREET, P.O. BOX 2397, RAANANA, 43650, ISRAEL
Covered Properties (2)
Material and Method for Treating Internal Cavities
Application: 14/720,676 →
Publication: US 2015/0366974
Material and Method for Treating Internal Cavities
Patent: 9,950,069 →
Application: 15/366,256 →
Publication: US 2017/0112935
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 8, 2018
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 044556/0637 →
Security Interest Apr 8, 2021
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICAV
Reel/Frame 055868/0385 →
Security Interest Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Amended and Restated Patent Security Agreement May 19, 2022
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICA V
Reel/Frame 060121/0591 →
Patent Security Agreement Mar 18, 2024
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066805/0346 →
Amended and Restated Patent Security Agreement Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Amended and Restated Patent Security Agreement Aug 18, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 072472/0233 →
Second Amended and Restated Patent Security Agreement Mar 2, 2026
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 074994/0338 →